A Prospective Study of Lumbar Facet Arthroplasty in the Treatment of Degenerative Spondylolisthesis and Stenosis: Early Cost-effective Assessment from the Total Posterior Spine System (TOPS™) IDE Study.

Background: Given the increased attention to functional improvement in spine surgery as it relates to motion preservation, activities of daily living, and cost, it is critical to fully understand the healthcare economic impact of new devices being tested in large FDA randomized controlled trials (RCT). The purpose of this analysis was to comprehensively evaluate the cost-effectiveness of the novel Total Posterior Spine (TOPS™) System investigational device compared with the trial control group, standard transforaminal lumbar interbody fusion (TLIF). Objective: To evaluate the cost-effectiveness of TOPS™ compared with TLIF. Methods: The study patient population was extracted from a multicenter RCT with current enrollment at n=121 with complete 1-year follow-up. The primary outcome was cost-effectiveness, expressed as the incremental cost-effectiveness ratio. Secondary outcomes were health-related utility, presented as quality-adjusted life-years (QALYs), and cost, calculated in US dollars. Analysis was conducted following Second Panel on Cost-Effectiveness Health and Medicine recommendations. The base case analysis utilized SF-36 survey data from the RCT. Both cost and QALY outcomes were discounted at a yearly rate of 3% to reflect their present value. A cohort Markov model was constructed to analyze perioperative and postoperative costs and QALYs for both TOPS™ and control groups. Scenario, probabilistic, and threshold sensitivity analyses were conducted to determine model discrimination and calibration. Results: The primary time horizon used to estimate cost and health utility was 2 years after index surgery. From a health system perspective, assuming a 50/50 split between Medicare and private payers, the TOPS™ cohort is cost-effective 2 years postoperatively ($6158/QALY) compared with control. At 6 years and beyond, TOPS™ becomes dominant, irrespective of payer mix and surgical setting. At willingness-to-pay thresholds of $100 000/QALY, 63% of all 5000 input parameter simulations favor TOPS, even with a $4000 upcharge vs TLIF. Discussion: The novel TOPS™ device is cost-effective compared with TLIF and becomes the dominant economic strategy over time. Conclusions: In the emerging, rapidly expanding field of value-based medicine, there will be an increased demand for these analyses, ensuring surgeons are empowered to make the best, most sustainable solutions for their patients and society.

Outcome of mechanical thrombectomy in the very elderly for the treatment of acute ischemic stroke: the real world experience.

BACKGROUND: Although initial studies of neuroendovascular intervention did not review benefit over intravenous thrombolytics (iv r-tPA), recent studies have suggested otherwise. Elderly patients (age ≥80 years) are typically excluded from clinical trials. PURPOSE: To examine the utility of mechanical thrombectomy based on patient outcomes. MATERIAL AND METHODS: All stroke-alert activations at our health system from January 2011 to June 2014 were examined. All patients aged ≥80 years who had undergone mechanical thrombectomy were identified. Clinical characteristics included physiologic imaging findings, use of intravenous thrombolytics, baseline and postoperative National Institute of Health Stroke Scale (NIHSS), thrombolysis in cerebral infarction scores (TICI), and discharge destination. RESULTS: Mean NIHSS on presentation was 18.2 (range, 6-31), and 13.3 (range, 3-30) post thrombectomy. Three (16.6%) patients received iv r-tPA, two (11.1%) had symptomatic intracranial hemorrhage. Eight (44.4%) died, eight (44.4%) were discharged to nursing homes, and two (11.7%) were discharged to inpatient rehab and subsequently home. Favorable outcome was achieved in five (27.7%) patients. Fourteen (77.7%) patients had physiologic imaging prior to intervention. Three (75%) of four patients who did not have physiologic imaging prior to thrombectomy died. Thirteen (66.6%) patients had TICI 3 recanalization. CONCLUSION: Our study showed that although there remains a role of mechanical thrombectomy in the treatment of acute ischemic stroke in very elderly patients, it is associated with significant higher morbidity and mortality compared to younger patients, but should remain a very viable treatment option when quality of life is the most important consideration.

Treatment of acute cervical internal carotid artery dissection using the Solitaire FR revascularization device.

During treatment of a right internal carotid artery terminus aneurysm, an acute iatrogenic flow limiting dissection was caused in the cervical internal carotid. The true lumen was catheterized using a Mirage 0.008 microwire over an Excelsior SL-10 microcatheter, which was exchanged for a Marksman microcatheter. A 6 mm × 30 mm Solitaire FR revascularization device was then deployed across the dissection as a salvage technique.

Treatment of acute cervical internal carotid artery dissection using the Solitaire FR revascularization device.

During treatment of a right internal carotid artery terminus aneurysm, an acute iatrogenic flow limiting dissection was caused in the cervical internal carotid. The true lumen was catheterized using a Mirage 0.008 microwire over an Excelsior SL-10 microcatheter, which was exchanged for a Marksman microcatheter. A 6 mm×30 mm Solitaire FR revascularization device was then deployed across the dissection as a salvage technique.

Management of one hundred seventy-one operative and nonoperative obstetrical birth palsies at the Louisiana State University Health Sciences Center.

OBJECTIVE: The management of obstetrical brachial plexus injury, often called birth palsy, remains one of the most controversial topics in pediatric neurosurgery. Most birth palsies have acceptable spontaneous recoveries, whereas only a minority require surgical intervention. A selective approach for surgery was used in this Louisiana State University Health Sciences Center (LSUHSC) series, for which the operative rate was 9%. At LSUHSC, the patient with obstetrical brachial plexus injury is followed for 6 to 9 months before surgery, which is performed if there is no satisfactory biceps and/or shoulder function. METHODS: This is a retrospective analysis of 169 patients with 171 palsies referred to LSUHSC for possible surgery. There were 76 patients with 77 birth palsies managed operatively and nonoperatively at LSUHSC between 1975 and 1991. An additional 93 patients with 94 palsies who were managed between 1992 and 2003 were included in this analysis. The results of initial and follow-up examinations using Eng's criteria for impairment ratings (IRs) were available for 151 of 171 (88%) nonoperative and operative obstetrical brachial plexus injuries managed between 1975 and 2001. RESULTS: Fifty-two percent of the nonoperative patients evaluated at an initial visit had an IR of 4 or 5, which represents very poor function by comparison to IR of 1 in the Eng scale, which represents almost no abnormality. The percentage of patients in this category (4-5) improved to 30% after follow-up visits. For the 16 operative cases, the initial and follow-up percentages of patients with IRs of 4 or 5 were 67% and 22%, respectively. Ultimately, 47% of the nonoperative patients achieved a grade 2 IR after follow-up compared with 17% of the operative patients. CONCLUSION: Using this selective approach at LSUHSC, in which the operative rate was 9%, acceptable outcomes were obtained both in patients not having surgery and also in those having surgical intervention.